Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic approach to hyponatremia.

Dae-Suk Han1, Byoung-Soo Cho

  • 1Department of Internal Medicine, College of Medicine, Yonsei University, Korea. dshan@yumc.yonsei.ac.kr

Nephron
|October 29, 2002
PubMed
Summary

Hyponatremia, a common hospital disorder, requires careful treatment balancing risks. Optimal management considers patient volume status, symptoms, duration, and risk factors to prevent neurologic complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimal proteinuria target for renoprotection in patients with IgA nephropathy.

PloS one·2014
Same author

Association of FOS-like antigen 1 promoter polymorphism with podocyte foot process effacement in immunoglobulin A nephropathy patients.

Journal of clinical laboratory analysis·2014
Same author

Association of BH3 interacting domain death agonist (BID) gene polymorphisms with proteinuria of immunoglobulin A nephropathy.

Scandinavian journal of clinical and laboratory investigation·2014
Same author

Decreased circulating klotho levels in patients undergoing dialysis and relationship to oxidative stress and inflammation.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2014
Same author

Factors associated with Hypokalemia in Continuous Ambulatory Peritoneal Dialysis Patients.

Electrolyte & blood pressure : E & BP·2014
Same author

A polymorphism of interleukin-22 receptor alpha-1 is associated with the development of childhood IgA nephropathy.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2013

Area of Science:

  • Internal Medicine
  • Nephrology
  • Neurology

Background:

  • Hyponatremia affects up to 6% of hospitalized patients, ranging from asymptomatic to life-threatening.
  • Severe symptomatic hyponatremia is a medical emergency, but treatment can cause central nervous system demyelination.

Purpose of the Study:

  • To outline a therapeutic strategy for hyponatremia management.
  • To identify key factors for optimizing treatment and minimizing neurologic complications.

Main Methods:

  • Categorization based on extracellular fluid (ECF) volume status.
  • Assessment of symptom presence, hyponatremia duration, and risk factors for neurologic complications.
  • Consideration of hyponatremia severity (serum sodium > 120 mEq/l).

Main Results:

  • ECF volume status is crucial for initial therapy determination.
  • Brain adaptation to hyponatremia depends on duration and symptoms.
  • Specific patient subgroups are at higher risk for treatment-induced neurologic complications.

Conclusions:

  • Optimal hyponatremia therapy requires individualized risk-benefit assessment.
  • Consensus guidelines provide a rational approach to minimize neurologic complications.
  • Balancing the risks of hyponatremia and its correction is essential for patient safety.

Related Experiment Videos